{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-067579","form_type":"8-K","ticker":"MIST","cik":"0001408443","company_name":"Milestone Pharmaceuticals Inc.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.910534+00:00","generated_at":"2026-05-18T06:37:40.975239+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Milestone Pharmaceuticals prices $52.5M public offering of common shares and warrants","bullets":["Priced $52.5M offering of 31.5M common shares + Series A and B warrants at $1.50/unit; 3.5M pre-funded warrants at $1.499/unit.","Net proceeds expected ~$48.7M after underwriting commissions and expenses.","Series A warrants exercisable at $1.50 for 1 year; Series B at $1.875 for 5 years, with mandatory exercise trigger at $3.50 VWAP.","Proceeds to fund etripamil clinical development and commercial launch for paroxysmal supraventricular tachycardia (PSVT).","Offering led by TD Cowen, Piper Sandler, Wells Fargo; expected to close July 14, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-067579","json":"https://secwatch.observer/filing/0001104659-25-067579.json","markdown":"https://secwatch.observer/filing/0001104659-25-067579.md","text":"https://secwatch.observer/filing/0001104659-25-067579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925067579/0001104659-25-067579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1408443/000110465925067579/tm2520713d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:37:40.975239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}